NCT00503139View on ClinicalTrials.gov

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

CompletedOBSERVATIONAL

Enrollment

684

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Enbrel (etanercept)

Enbrel 10 to 25 mg twice a week subcutaneous injection

Trial Locations (1)

060-8638

Hokkaido University Hospital, Sapporo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY